This inventor holds 2 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Agenebio, Inc.. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: The Innovative Contributions of Elsie Melsopp
Introduction
Elsie Melsopp is a notable inventor based in Wilmington, NC (US), recognized for her significant contributions to the field of pharmaceuticals. With a total of two patents to her name, she has made strides in developing innovative solutions for cognitive impairment associated with central nervous system disorders.
Latest Patents
Melsopp's latest patents focus on extended release pharmaceutical compositions of levetiracetam. This invention relates to novel formulations that enhance the delivery and effectiveness of levetiracetam, a medication commonly used to treat epilepsy. The extended release compositions are designed to improve patient outcomes by providing a sustained therapeutic effect, particularly for individuals experiencing cognitive impairment linked to central nervous system disorders.
Career Highlights
Throughout her career, Elsie Melsopp has worked with various companies, including Agenebio, Inc. and Aaipharma Services Corporation. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical development and innovation.
Collaborations
Melsopp has collaborated with esteemed colleagues such as Michela Gallagher and Sharon J Rosenzweig-Lipson. These partnerships have contributed to her success in advancing pharmaceutical research and development.
Conclusion
Elsie Melsopp's work exemplifies the impact of innovation in the pharmaceutical industry. Her patents and collaborations highlight her commitment to improving treatments for cognitive impairments, showcasing her as a key figure in her field.